Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial.
Sun J, Song Y, Gong Y, Tao L, Wang H, Shu X, Wen Y, Cui L, Ye J, Lu S, Deng J, Li H, Xu Y, Qian L, Wu Z, Bi Y, Liu Q, Xu X, Wu M, Zhang J, Hao J, Tong J, Dai H, Wang F, Zhao M, Mao J, Li C, He T, Pei C, Liu X, Wang X, Li M, Wang W, Zheng Q, Guan H, Peng H, Fan K, Zhang W, Zhu D, Yu S, Wei W, Ding L, Li J, Lu P, Yan M, Liu W, Jia H, Sun X.
Sun J, et al. Among authors: ye j.
Ophthalmol Retina. 2024 Aug 29:S2468-6530(24)00401-9. doi: 10.1016/j.oret.2024.08.014. Online ahead of print.
Ophthalmol Retina. 2024.
PMID: 39214250